MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,792,000 | -86.3% | 2,248,986 | -66.0% | 0.00% | -100.0% |
| Q1 2017 | $20,364,000 | -6.7% | 6,611,230 | +23.6% | 0.00% | 0.0% |
| Q4 2016 | $21,829,000 | -25.1% | 5,349,447 | +16.5% | 0.00% | -33.3% |
| Q3 2016 | $29,163,000 | +38.4% | 4,592,802 | +17.5% | 0.00% | +50.0% |
| Q2 2016 | $21,066,000 | -15.2% | 3,908,674 | +31.7% | 0.00% | -33.3% |
| Q1 2016 | $24,850,000 | -8.3% | 2,968,888 | -13.5% | 0.00% | 0.0% |
| Q4 2015 | $27,105,000 | -21.2% | 3,431,068 | -15.2% | 0.00% | -25.0% |
| Q3 2015 | $34,415,000 | -30.2% | 4,044,084 | +1.5% | 0.00% | -20.0% |
| Q2 2015 | $49,277,000 | +19.7% | 3,985,109 | +15.0% | 0.01% | +25.0% |
| Q1 2015 | $41,171,000 | +13.5% | 3,465,430 | +8.0% | 0.00% | 0.0% |
| Q4 2014 | $36,260,000 | +12.5% | 3,208,406 | -12.6% | 0.00% | +33.3% |
| Q3 2014 | $32,240,000 | +30.1% | 3,672,150 | +8.0% | 0.00% | 0.0% |
| Q2 2014 | $24,780,000 | +5.9% | 3,399,276 | -26.8% | 0.00% | 0.0% |
| Q1 2014 | $23,398,000 | +155.9% | 4,641,622 | +176.1% | 0.00% | +200.0% |
| Q4 2013 | $9,145,000 | +89.9% | 1,681,044 | +32.7% | 0.00% | 0.0% |
| Q3 2013 | $4,816,000 | -38.7% | 1,267,277 | +8.6% | 0.00% | 0.0% |
| Q2 2013 | $7,855,000 | – | 1,167,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|